Verrica Pharmaceuticals Inc. Litigation Settlement, Expense
Verrica Pharmaceuticals Inc. (VRCA) reported Litigation Settlement, Expense of $0 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2024-11-05
- Verrica Pharmaceuticals Inc. litigation settlement, expense for the quarter ending 2024-09-30 was $0.00.
- Verrica Pharmaceuticals Inc. litigation settlement, expense for the quarter ending 2024-06-30 was $800.00K.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-05 | $800.00K derived: sum of 2 quarters · filed 2024-11-05 | $800.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $800.00K 10-Q · filed 2024-08-14 | $800.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |